It has been reported as having anticancer activity in multiple cancer xenograft models by inhibiting the neddylation pathway and therefore abolishing Cullin neddylation and CRL activities that induce the accumulation of tumor-suppressive substrates to impair cancer cell growth and result in cell apoptosis and senescence (9, 19, 21–26). The gene discussed is IL31RA; the disease is cancer.